Proton therapy

Mevion to Highlight FLASH Therapy Momentum at ASTRO 2020

Retrieved on: 
Thursday, October 22, 2020
Biotechnology, General Health, Health, Oncology, Medical physics, Medicine, Radiation therapy, Radiobiology, Physical sciences, Health sciences, Proton, Proton therapy, Pencil-beam scanning, Pencil, Particle accelerator, Therapy

At the first virtual meeting of the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, October 23rd to the 29th, Mevion will highlight its research and development progress demonstrating the FLASH effect on commercially available MEVION S250i compact proton accelerators.

Key Points: 
  • At the first virtual meeting of the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, October 23rd to the 29th, Mevion will highlight its research and development progress demonstrating the FLASH effect on commercially available MEVION S250i compact proton accelerators.
  • ASTRO attendees are invited to visit the Mevion virtual booth to talk to our team about Mevion proton therapy solutions, FLASH Therapy progress, IGPT customizations, and to learn more about how Mevion has changed proton therapy.
  • Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care.
  • Mevions flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the worlds smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems.

Mevion Partners with Hermes Advanced Therapy Systems to Expand Reach in Asia

Retrieved on: 
Monday, October 19, 2020
Biotechnology, Health, Oncology, Medical physics, Radiation therapy, Health sciences, Medicine, Applied sciences, Proton, Proton therapy, Radiobiology, Pencil-beam scanning, Pencil, Therapy

Mevion Medical Systems is pleased to announce it has entered a partnership agreement with Hermes Advanced Therapy Systems Corp .

Key Points: 
  • Mevion Medical Systems is pleased to announce it has entered a partnership agreement with Hermes Advanced Therapy Systems Corp .
  • Adoption of proton therapy has been expanding rapidly because of the development of compact proton therapy systems.
  • We are proud to have a well-established partner such as Hermes Advanced Therapy Systems as our extended team in Taiwan and Southeast Asia, said James Meng, Ph.D. president of Mevion Medical Systems.
  • Mevions flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the worlds smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems.

Mevion Ships the First Compact Accelerator Module to China

Retrieved on: 
Thursday, October 15, 2020
Oncology, Medical devices, Health, Hospitals, Radiology, Biotechnology, Health sciences, Medical physics, Proton, Physical sciences, Medicine, Proton therapy, Therapy, Dielectric wall accelerator

Mevion Medical Systems announced today that it has shipped the accelerator module for the MEVION S250i Proton Therapy System to Kunshan, China.

Key Points: 
  • Mevion Medical Systems announced today that it has shipped the accelerator module for the MEVION S250i Proton Therapy System to Kunshan, China.
  • The 15-ton compact accelerator, the heart of the proton therapy system, is the smallest of its kind and will be the first in China.
  • View the full release here: https://www.businesswire.com/news/home/20201015005359/en/
    Mevion's compact accelerator module is lifted and placed on a truck for the first leg of its journey to China.
  • Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care.

Proton Therapy Partners Names Kevin Kriebel Vice President of Construction & Architectural Management

Retrieved on: 
Tuesday, October 6, 2020
Medical physics, Health sciences, Medicine, Physical sciences, Proton, Proton therapy, Particle therapy, University of Florida, Therapy

PHILADELPHIA, Oct. 6, 2020 /PRNewswire/ -- Proton Therapy Partners (PTP) has named Kevin Kriebel Vice President of Construction and Architectural Management.

Key Points: 
  • PHILADELPHIA, Oct. 6, 2020 /PRNewswire/ -- Proton Therapy Partners (PTP) has named Kevin Kriebel Vice President of Construction and Architectural Management.
  • In this role, Kevin will lead the planning and building of PTP's proton therapy centers nationwide.
  • Kevin is the most accomplished, experienced, and reputable expert in the design and construction of particle therapy centers.
  • Kevin is a graduate of the University of Florida, a member of Proton Therapy Cooperative Group and is OSHA 30 certified.

Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1

Retrieved on: 
Tuesday, September 15, 2020
Radiation therapy, Medical physics, Medicine, Proton therapy, Radiation treatment planning, Academic disciplines, Siemens Healthineers, Physics, Varian Medical Systems

Graphics Processing Unit (GPU) accelerates the speed of Monte Carlo proton dose calculation and improves efficiency in treatment planning.

Key Points: 
  • Graphics Processing Unit (GPU) accelerates the speed of Monte Carlo proton dose calculation and improves efficiency in treatment planning.
  • Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning software for proton therapy.
  • With the release of Eclipse v16.1 treatment planning software, Varian introduces intelligent treatment planning features, leveraging Siemens Healthineers' SOMATOM DECTdiagnostic imagerwith its dual x-ray energies capability.
  • This technology enables clinicians to accelerate calculation speed and improve overall treatment planning efficiency..
    "As a leader in proton therapy, Varian's goal is to drive the next evolution of proton treatment planning by providing intelligent tools designed to improve plan quality, accelerate speed of dose calculations, and provide new levels of accuracy," said Kolleen Kennedy, President, Proton Solutions & Chief Growth Officer, Varian.

United States Radiation Oncology Market Size, Share & Trends Analysis Report, 2020-2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 15, 2020
Radiology, Health, Oncology, Medical physics, Radiobiology, Medicine, Radiation therapy, Radioactivity, Physical sciences, Nuclear physics, Oncology, Proton therapy, Radiation therapist

Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Technology, by Application, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Technology, by Application, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. radiation oncology market size is expected to reach USD 3.9 billion by 2027, expanding at a CAGR of 5.0%
    Increasing the prevalence of cancer and technological advancements in radiation oncology are some of the key factors responsible for market growth.
  • Advancements in technologies are anticipated to reduce the adverse effects of radiotherapy and improve its overall quality.
  • Advancements in radiation oncology can enable the delivery of a high dose to a target area without any damage to adjacent healthy tissues.

Mevion and Proton International to Partner on Two Proton Therapy Centers

Retrieved on: 
Tuesday, September 1, 2020
Oncology, Medical devices, Health, Hospitals, Radiology, Biotechnology, Radiation therapy, Medical physics, Medicine, Health sciences, Applied sciences, Proton therapy, Pencil-beam scanning, Pencil, Proton, HyperScan, Therapy

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    The new centers will feature the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS).
  • Today, more cancer centers are considering providing compact proton therapy to their patients because of the technology Mevion has advanced.
  • Mevions flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the worlds smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems.
  • Connect with us on LinkedIn: Mevion Medical Systems
    Proton International, www.protonintl.com , has an experienced team dedicated to bringing proton therapy to patients.

American Shared Hospital Services Reports Second Quarter 2020 Financial Results

Retrieved on: 
Friday, August 14, 2020
Medical physics, Nuclear physics, Finance, Radiation therapy, Physical sciences, Radiobiology, Earnings before interest, taxes, depreciation, and amortization, Fundamental analysis, Profit, Proton therapy, Income, PROTON Holdings

SAN FRANCISCO, CA, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the second quarter ended June 30, 2020.

Key Points: 
  • SAN FRANCISCO, CA, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the second quarter ended June 30, 2020.
  • Total proton therapy fractions in the second quarter decreased 4.1% compared to the second quarter of 2019.The decrease for the second quarter resulted from the impact of the COVID-19 pandemic.
  • Net loss in the second quarter was $483,000 compared to net income of $31,000 for the second quarter of 2019.
  • Adjusted EBITDA, a non-GAAP financial measure, was $1,437,000 for the second quarter of 2020, compared to $2,465,000 for the second quarter of 2019.

Mevion Selected to Provide Proton Therapy System in Córdoba, Spain

Retrieved on: 
Wednesday, August 5, 2020
Oncology, Health, Medical devices, Hospitals, Other Health, Radiology, Biotechnology, Medical physics, Medicine, Physical sciences, Academic disciplines, Radiobiology, Proton, Pencil-beam scanning, Proton therapy, Pencil, Radiation therapy, Therapy

In the initiative, Mevion will provide its revolutionary MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning which will be made available to Andalusian Health Service patients.

Key Points: 
  • In the initiative, Mevion will provide its revolutionary MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning which will be made available to Andalusian Health Service patients.
  • View the full release here: https://www.businesswire.com/news/home/20200805005278/en/
    MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning.
  • To learn more about the proton therapy initiative in Crdoba, Spain, please see the University of Cordoba's announcement .
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

Proton Therapy Experts Gather Online for First Virtual National Proton Conference on July 24th 2020

Retrieved on: 
Wednesday, July 22, 2020
Health sciences, Medical physics, Radiation therapy, Health, Proton, Proton therapy, Applied sciences, Therapy

Washington, DC, July 22, 2020 (GLOBE NEWSWIRE) -- Over 450 proton therapy experts from across the globe are registered to attend the National Proton Conference virtually on Friday July 24th.

Key Points: 
  • Washington, DC, July 22, 2020 (GLOBE NEWSWIRE) -- Over 450 proton therapy experts from across the globe are registered to attend the National Proton Conference virtually on Friday July 24th.
  • The virtual event offers flexibility and an opportunity to learn in the comfort and safety of your home or office.
  • The National Association for Proton Therapy (NAPT) is an independent nonprofit organization founded in 1990 to educate and increase awareness about the clinical benefits of proton therapy.
  • The mission of NAPT is to work collaboratively to raise public awareness of the clinical benefits of proton therapy, ensure patients choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.